Study abstracts released Thursday give investors and analysts a better look at cancer treatments recently licensed by Merck and BioNTech as well as fresh details on other closely watched ADC candidates.
News Ticker
- [ June 6, 2023 ] Warehouse Associate III – Legend Biotech US – Raritan, NJ Jobs
- [ June 6, 2023 ] AHN, Cigna contract battle threatens to cut in-network coverage to up to 20K News
- [ June 6, 2023 ] Manager/Sr Mgr- Gross to Net & Government Pricing (Finance) – Kedrion Biopharma Inc. – Fort Lee, NJ Jobs
- [ June 6, 2023 ] Associate Director, Operations Portfolio Lead – Cell Therapy – Bristol Myers Squibb – Summit, NJ Jobs
- [ June 6, 2023 ] Associate Director, Operations Portfolio Lead – Cell Therapy – Bristol Myers Squibb – Princeton, NJ Jobs
Copyright © 2023 Biotech Networks, LLC
Be the first to comment